330 related articles for article (PubMed ID: 31005273)
1. Low levels of urinary epidermal growth factor predict chronic kidney disease progression in children.
Azukaitis K; Ju W; Kirchner M; Nair V; Smith M; Fang Z; Thurn-Valsassina D; Bayazit A; Niemirska A; Canpolat N; Bulut IK; Yalcinkaya F; Paripovic D; Harambat J; Cakar N; Alpay H; Lugani F; Mencarelli F; Civilibal M; Erdogan H; Gellermann J; Vidal E; Tabel Y; Gimpel C; Ertan P; Yavascan O; Melk A; Querfeld U; Wühl E; Kretzler M; Schaefer F; ;
Kidney Int; 2019 Jul; 96(1):214-221. PubMed ID: 31005273
[TBL] [Abstract][Full Text] [Related]
2. Urinary epidermal growth factor as a prognostic marker for the progression of Alport syndrome in children.
Li B; Zhang Y; Wang F; Nair V; Ding F; Xiao H; Yao Y; Kretzler M; Ju W; Ding J
Pediatr Nephrol; 2018 Oct; 33(10):1731-1739. PubMed ID: 29948307
[TBL] [Abstract][Full Text] [Related]
3. Association of Serum Soluble Urokinase Receptor Levels With Progression of Kidney Disease in Children.
Schaefer F; Trachtman H; Wühl E; Kirchner M; Hayek SS; Anarat A; Duzova A; Mir S; Paripovic D; Yilmaz A; Lugani F; Arbeiter K; Litwin M; Oh J; Matteucci MC; Gellermann J; Wygoda S; Jankauskiene A; Klaus G; Dusek J; Testa S; Zurowska A; Caldas Afonso A; Tracy M; Wei C; Sever S; Smoyer W; Reiser J;
JAMA Pediatr; 2017 Nov; 171(11):e172914. PubMed ID: 28873129
[TBL] [Abstract][Full Text] [Related]
4. Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.
Ju W; Nair V; Smith S; Zhu L; Shedden K; Song PXK; Mariani LH; Eichinger FH; Berthier CC; Randolph A; Lai JY; Zhou Y; Hawkins JJ; Bitzer M; Sampson MG; Thier M; Solier C; Duran-Pacheco GC; Duchateau-Nguyen G; Essioux L; Schott B; Formentini I; Magnone MC; Bobadilla M; Cohen CD; Bagnasco SM; Barisoni L; Lv J; Zhang H; Wang HY; Brosius FC; Gadegbeku CA; Kretzler M;
Sci Transl Med; 2015 Dec; 7(316):316ra193. PubMed ID: 26631632
[TBL] [Abstract][Full Text] [Related]
5. Urinary neutrophil gelatinase-associated lipocalin may aid prediction of renal decline in patients with non-proteinuric Stages 3 and 4 chronic kidney disease (CKD).
Smith ER; Lee D; Cai MM; Tomlinson LA; Ford ML; McMahon LP; Holt SG
Nephrol Dial Transplant; 2013 Jun; 28(6):1569-79. PubMed ID: 23328709
[TBL] [Abstract][Full Text] [Related]
6. Associations of urinary epidermal growth factor and monocyte chemotactic protein-1 with kidney involvement in patients with diabetic kidney disease.
Wu L; Li XQ; Chang DY; Zhang H; Li JJ; Wu SL; Zhang LX; Chen M; Zhao MH
Nephrol Dial Transplant; 2020 Feb; 35(2):291-297. PubMed ID: 30357416
[TBL] [Abstract][Full Text] [Related]
7. Urine Biomarkers of Kidney Tubule Health, Injury, and Inflammation are Associated with Progression of CKD in Children.
Greenberg JH; Abraham AG; Xu Y; Schelling JR; Feldman HI; Sabbisetti VS; Ix JH; Jogalekar MP; Coca S; Waikar SS; Shlipak MG; Warady BA; Vasan RS; Kimmel PL; Bonventre JV; Denburg M; Parikh CR; Furth S; ;
J Am Soc Nephrol; 2021 Oct; 32(10):2664-2677. PubMed ID: 34544821
[TBL] [Abstract][Full Text] [Related]
8. Urinary excretion of epidermal growth factor and rapid loss of kidney function.
Norvik JV; Harskamp LR; Nair V; Shedden K; Solbu MD; Eriksen BO; Kretzler M; Gansevoort RT; Ju W; Melsom T
Nephrol Dial Transplant; 2021 Sep; 36(10):1882-1892. PubMed ID: 33068410
[TBL] [Abstract][Full Text] [Related]
9. Urinary epidermal growth factor, monocyte chemoattractant protein-1 or their ratio as predictors for rapid loss of renal function in type 2 diabetic patients with diabetic kidney disease.
Satirapoj B; Dispan R; Radinahamed P; Kitiyakara C
BMC Nephrol; 2018 Sep; 19(1):246. PubMed ID: 30241508
[TBL] [Abstract][Full Text] [Related]
10. Urinary epidermal growth factor predicts renal prognosis in antineutrophil cytoplasmic antibody-associated vasculitis.
Wu L; Li XQ; Goyal T; Eddy S; Kretzler M; Ju WJ; Chen M; Zhao MH
Ann Rheum Dis; 2018 Sep; 77(9):1339-1344. PubMed ID: 29724728
[TBL] [Abstract][Full Text] [Related]
11. Progression of pediatric CKD of nonglomerular origin in the CKiD cohort.
Fathallah-Shaykh SA; Flynn JT; Pierce CB; Abraham AG; Blydt-Hansen TD; Massengill SF; Moxey-Mims MM; Warady BA; Furth SL; Wong CS
Clin J Am Soc Nephrol; 2015 Apr; 10(4):571-7. PubMed ID: 25635034
[TBL] [Abstract][Full Text] [Related]
12. Association of the Urine-to-Plasma Urea Ratio With CKD Progression.
Liu J; Bankir L; Verma A; Waikar SS; Palsson R
Am J Kidney Dis; 2023 Apr; 81(4):394-405. PubMed ID: 36356680
[TBL] [Abstract][Full Text] [Related]
13. Albuminuria, Proteinuria, and Renal Disease Progression in Children with CKD.
Fuhrman DY; Schneider MF; Dell KM; Blydt-Hansen TD; Mak R; Saland JM; Furth SL; Warady BA; Moxey-Mims MM; Schwartz GJ
Clin J Am Soc Nephrol; 2017 Jun; 12(6):912-920. PubMed ID: 28546440
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 and epidermal growth factor as noninvasive biomarkers of progression in chronic glomerulonephritis.
Idasiak-Piechocka I; Miedziaszczyk M; Woźniak A; Pawliczak E; Kaczmarek E; Oko A
Am J Physiol Cell Physiol; 2023 Nov; 325(5):C1267-C1275. PubMed ID: 37721004
[TBL] [Abstract][Full Text] [Related]
15. Estimating Time to ESRD in Children With CKD.
Furth SL; Pierce C; Hui WF; White CA; Wong CS; Schaefer F; Wühl E; Abraham AG; Warady BA; ;
Am J Kidney Dis; 2018 Jun; 71(6):783-792. PubMed ID: 29653769
[TBL] [Abstract][Full Text] [Related]
16. Association of Urinary Oxalate Excretion With the Risk of Chronic Kidney Disease Progression.
Waikar SS; Srivastava A; Palsson R; Shafi T; Hsu CY; Sharma K; Lash JP; Chen J; He J; Lieske J; Xie D; Zhang X; Feldman HI; Curhan GC;
JAMA Intern Med; 2019 Apr; 179(4):542-551. PubMed ID: 30830167
[TBL] [Abstract][Full Text] [Related]
17. Urinary Epidermal Growth Factor: A Promising "Next Generation" Biomarker in Kidney Disease.
Cortvrindt C; Speeckaert R; Delanghe JR; Speeckaert MM
Am J Nephrol; 2022; 53(5):372-387. PubMed ID: 35537382
[TBL] [Abstract][Full Text] [Related]
18. Predictors of Rapid Progression of Glomerular and Nonglomerular Kidney Disease in Children and Adolescents: The Chronic Kidney Disease in Children (CKiD) Cohort.
Warady BA; Abraham AG; Schwartz GJ; Wong CS; Muñoz A; Betoko A; Mitsnefes M; Kaskel F; Greenbaum LA; Mak RH; Flynn J; Moxey-Mims MM; Furth S
Am J Kidney Dis; 2015 Jun; 65(6):878-88. PubMed ID: 25799137
[TBL] [Abstract][Full Text] [Related]
19. Fasting Urinary Osmolality, CKD Progression, and Mortality: A Prospective Observational Study.
Tabibzadeh N; Wagner S; Metzger M; Flamant M; Houillier P; Boffa JJ; Vrtovsnik F; Thervet E; Stengel B; Haymann JP;
Am J Kidney Dis; 2019 May; 73(5):596-604. PubMed ID: 30777634
[TBL] [Abstract][Full Text] [Related]
20. The ASSESS-AKI Study found urinary epidermal growth factor is associated with reduced risk of major adverse kidney events.
Menez S; Wen Y; Xu L; Moledina DG; Thiessen-Philbrook H; Hu D; Obeid W; Bhatraju PK; Ikizler TA; Siew ED; Chinchilli VM; Garg AX; Go AS; Liu KD; Kaufman JS; Kimmel PL; Himmelfarb J; Coca SG; Cantley LG; Parikh CR
Kidney Int; 2023 Dec; 104(6):1194-1205. PubMed ID: 37652206
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
